Alterations in One-Carbon Metabolism in Celiac Disease
MetadatosMostrar el registro completo del ítem
Amino acidsCholineCeliac diseaseFolate cycleMass spectrometryMethionine cycleMethionine savage pathwayTranssulfuration pathway
Martín-Masot, R., Mota-Martorell, N., Jové, M., Maldonado, J., Pamplona, R., & Nestares, T. (2020). Alterations in One-Carbon Metabolism in Celiac Disease. Nutrients, 12(12), 3723. [doi:10.3390/nu12123723]
PatrocinadorJunta de Andalucía P12-AGR-2581; Spanish Ministry of Science, Innovation, and Universities (Ministerio de Ciencia, Innovacion y Universidades) RTI2018-099200-BI00; Generalitat of Catalonia: Agency for Management of University and Research Grants 2017SGR696; Department of Health SLT002/16/00250; European Union (EU); Grant "Investigation grant program by the SPAO" 2020 edition
Celiac disease (CD) is an autoimmune enteropathy associated with alterations of metabolism. Metabolomics studies, although limited, showed changes in choline, choline-derived lipids, and methionine concentrations, which could be ascribed to alterations in one-carbon metabolism. To date, no targeted metabolomics analysis investigating di erences in the plasma choline/methionine metabolome of CD subjects are reported. This work is a targeted metabolomic study that analyzes 37 metabolites of the one-carbon metabolism in 17 children with CD, treated with a gluten-free diet and 17 healthy control siblings, in order to establish the potential defects in this metabolic network. Our results demonstrate the persistence of defects in the transsulfuration pathway of CD subjects, despite dietary treatment, while choline metabolism, methionine cycle, and folate cycle seem to be reversed and preserved to healthy levels. These findings describe for the first time, a metabolic defect in one-carbon metabolism which could have profound implications in the physiopathology and treatment of CD.